Michael Gelband’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Sell
28,523
-51,307
-64% -$3.69M 0.01% 792
2026
Q1
$5.69M Buy
+79,830
New +$5.46M 0.05% 404
2025
Q4
Sell
-9,044
Closed -$499K 1894
2025
Q3
$499K Buy
+9,044
New +$470K 0.01% 1184
2025
Q2
Sell
-13,155
Closed -$521K 1807
2025
Q1
$521K Buy
+13,155
New +$582K 0.01% 1102
2024
Q2
Sell
-5,829
Closed -$278K 1824
2024
Q1
$278K Buy
+5,829
New +$262K ﹤0.01% 1277
2023
Q1
Sell
-25,350
Closed -$1.79M 2007
2022
Q4
$1.79M Sell
25,350
-34,410
-58% -$2.43M 0.03% 693
2022
Q3
$3.62M Buy
59,760
+48,480
+430% +$3.25M 0.05% 522
2022
Q2
$712K Buy
+11,280
New +$735K 0.01% 1224
2022
Q1
Sell
-6,286
Closed -$451K 2525
2021
Q4
$451K Sell
6,286
-6,691
-52% -$509K ﹤0.01% 1472
2021
Q3
$926K Sell
12,977
-4,321
-25% -$341K 0.01% 1064
2021
Q2
$1.41M Buy
+17,298
New +$1.39M 0.02% 831
2020
Q4
Sell
-13,801
Closed -$682K 2243
2020
Q3
$682K Sell
13,801
-38,449
-74% -$2.17M 0.01% 854
2020
Q2
$2.75M Buy
52,250
+28,868
+123% +$1.37M 0.07% 313
2020
Q1
$823K Buy
+23,382
New +$1.37M 0.05% 346
2019
Q4
Sell
-2,384
Closed -$202K 1764
2019
Q3
$202K Buy
+2,384
New +$212K 0.01% 1122
2019
Q2
Sell
-2,903
Closed -$307K 1260
2019
Q1
$307K Buy
+2,903
New +$292K 0.02% 460

Other funds holding NGVT

Michael Gelband's NGVT Position: Q2 2026 in Review

Michael Gelband reduced its Ingevity (NGVT) stake by 64% in Q2 2026, selling an estimated $3.69M and leaving 28,523 shares worth $2.13M. The position accounts for 0.01% of the portfolio, ranked #792.

Michael Gelband first reported a position in NGVT in Q1 2019 and has held it in 16 quarters since. The position peaked at $5.69M in Q1 2026. 312 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Michael Gelband held 28,523 shares of Ingevity worth $2.13M as of Q2 2026.
  • Michael Gelband sold 51,307 Ingevity shares in Q2 2026, an estimated $3.69M.
  • Ingevity made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #792 holding.
  • Michael Gelband first reported a position in Ingevity in Q1 2019 and has held it in 16 quarters since.
  • Michael Gelband's Ingevity position peaked at $5.69M in Q1 2026.
  • 312 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.